PPIs shown to increase fracture risk in dialysis patients
The use of proton pump inhibitors (PPIs) was associated with a 19% higher risk of hip fracture in patients with kidney failure on dialysis, as per a study published Sept. 27, 2018 in the Clinical Journal of the American Society of Nephrology (CJASN). The association remained within subgroups of low, moderate, and high use, yielding of 16%, 21%, and 19% greater risks, respectively. Histamine-2 receptor antagonists were not associated with hip fracture events.
To continue reading this article
Continue reading your article with a eMediNexus account.